Although the majority of MTCs are sporadic, in 25% of patients this malignancy occurs in a hereditary form as the dominant component of the Multiple Endocrine Neoplasia (MEN) type 2 syndromes, MEN2A and MEN2B, or familial MTC [3,4]. The gene discussed is RET; the disease is multiple endocrine neoplasia.